Ginkgo Bioworks Holdings
Open
$8.51
Prev. Close
$8.51
High
$8.52
Low
$8.44
Market Snapshot
$454.43M
-1.5
-10.64
$227.04M
485
Ginkgo Bioworks Holdings, Inc. is a biotech company. The company is headquartered in Boston, Massachusetts and currently employs 485 full-time employees. The company went IPO on 2021-04-19. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatics support services, offered to both government and non-government customers through its two core offerings: Canopy and Horizon. The firm provides comprehensive research and development services spanning the genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics.
emptyResult
Ginkgo Bioworks Holdings, Inc. is a biotech company. The company is headquartered in Boston, Massachusetts and currently employs 485 full-time employees. The company went IPO on 2021-04-19. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatics support services, offered to both government and non-government customers through its two core offerings: Canopy and Horizon. The firm provides comprehensive research and development services spanning the genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics.
Recently from Cashu
Groundbreaking Sperm DNA Packaging Research Offers Insights for Ginkgo Bioworks in Fertility Solutions
Unlocking the Secrets of Sperm DNA Packaging: A Breakthrough in Fertility Research Recent advancements from researchers at the Nano Life Science Institute (WPI-NanoLSI) at Kanazawa University provide…
Ginkgo Bioworks: Leading Sustainable Innovations in the Growing DNA Data Storage Market
Ginkgo Bioworks: Pioneering the Future of Sustainable Data Storage Ginkgo Bioworks Holdings stands at the forefront of the burgeoning DNA data storage market, which is projected to explode in size ove…
Ginkgo Bioworks Leads Innovation in Rapidly Growing DNA Data Storage Market
Ginkgo Bioworks Positioned at the Forefront of DNA Data Storage Innovations Ginkgo Bioworks Holdings operates in the rapidly evolving field of synthetic biology, and recent insights into the DNA Data…
Ginkgo Bioworks Holdings: Lucid Diagnostics Achieves Esophageal Cancer Screening Breakthrough in New York.
Groundbreaking Coverage for Esophageal Cancer Screening in New York Lucid Diagnostics Inc., a key player in cancer prevention medical diagnostics and a subsidiary of PAVmed Inc., recently achieves a s…